Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 4.5 % NASDAQ:EVOK opened at $1.05 on Thursday. The company has a quick ratio of 3.27, a current ratio of […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Downgrades Maiden (NASDAQ:MHLD) to Sell
Next post WEC Energy Group (NYSE:WEC) Lowered to “Sell” at StockNews.com